• 1
    Miller FW. Inflammatory myopathies: polymyositis, dermatomyositis, and related conditions. In: KoopmanW, MorelandsL, editors. Arthritis and allied conditions, a textbook of rheumatology. Philadelphia: Lippincott, Williams & Wilkins; 2004. p. 15931620.
  • 2
    Love LA, Leff RL, Fraser DD, Targoff IN, Dalakas M, Plotz PH, et al. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups. Medicine (Baltimore) 1991; 70: 36074.
  • 3
    Reed AM, Ytterberg SR. Genetic and environmental risk factors for idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002; 28: 891916.
  • 4
    O'Hanlon T, Koneru B, Bayat E, Love L, Targoff I, Malley J, et al. Immunogenetic differences between Caucasian women with and those without silicone implants in whom myositis develops. Arthritis Rheum 2004; 50: 364650.
  • 5
    Lampe JB, Gossrau G, Kempe A, Fussel M, Schwurack K, Schroder R, et al. Analysis of HLA class I and II alleles in sporadic inclusion-body myositis. J Neurol 2003; 250: 13137.
  • 6
    Davidson A, Diamond B. Autoimmune diseases. N Engl J Med 2001; 345: 34050.
  • 7
    Newton JL, Harney SM, Wordsworth BP, Brown MA. A review of the MHC genetics of rheumatoid arthritis. Genes Immun 2004; 5: 1517.
  • 8
    Thorsby E, Lie BA. HLA associated genetic predisposition to autoimmune diseases: genes involved and possible mechanisms. Transpl Immunol 2005; 14: 17582.
  • 9
    O'Hanlon TP, Carrick DM, Arnett FC, Reveille JD, Carrington M, Gao X, et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians. Medicine (Baltimore) 2005; 84: 33849.
  • 10
    Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nat Med 2001; 7: 899905.
  • 11
    Gebe JA, Swanson E, Kwok WW. HLA class II peptide-binding and autoimmunity. Tissue Antigens 2002; 59: 7887.
  • 12
    O'Hanlon TP, Mercatante-Carrick D, Targoff IN, Arnett FC, Reveille JD, Carrington M, et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European American patients with different myositis autoantibodies. Medicine (Baltimore) 2006; 85: 11127.
  • 13
    Reed AM, Stirling JD. Association of the HLA-DQA1*0501 allele in multiple racial groups with juvenile dermatomyositis. Hum Immunol 1995; 44: 1315.
  • 14
    Goldstein R, Duvic M, Targoff IN, Reichlin M, McMenemy AM, Reveille JD, et al. HLA-D region genes associated with autoantibody responses to histidyl–transfer RNA synthetase (Jo-1) and other translation–related factors in myositis. Arthritis Rheum 1990; 33: 12408.
  • 15
    Arnett FC, Targoff IN, Mimori T, Goldstein R, Warner NB, Reveille JD. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum 1996; 39: 150718.
  • 16
    Moulds JM, Rolih C, Goldstein R, Whittington KF, Warner NB, Targoff IN, et al. C4 null genes in American whites and blacks with myositis. J Rheumatol 1990; 17: 3314.
  • 17
    Morel PA, Chang HJ, Wilson JW, Conte C, Saidman SL, Bray JD, et al. Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele. Hum Immunol 1994; 40: 10110.
  • 18
    Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV. Anti–signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum 2004; 50: 20915.
  • 19
    Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975; 292: 3447.
  • 20
    Gibert M, Balandraud N, Touinssi M, Mercier P, Roudier J, Reviron D. Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: the protective effect. Hum Immunol 2003; 64: 9305.
  • 21
    Targoff IN. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine: two additional synthetases are antigenic in myositis. J Immunol 1990; 144: 173743.
  • 22
    Targoff IN, Trieu EP, Miller FW. Reaction of anti-OJ autoantibodies with components of the multi-enzyme complex of aminoacyl-tRNA synthetases in addition to isoleucyl-tRNA synthetase. J Clin Invest 1993; 91: 255664.
  • 23
    Holm S. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statististics 1979; 6: 6570.
  • 24
    Friedman JH, Hastie T, Tibshirani R. The elements of statistical learning: data mining, inference, and prediction. New York: Springer-Verlag; 2001.
  • 25
    Schwede T, Kopp J, Guex N, Peitsch MC. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 2003; 31: 33815.
  • 26
    Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006; 22: 195201.
  • 27
    Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res 2000; 28: 23542.
  • 28
    Gans CP, Tang TF, Slack R, Ng J, Hartzman RJ, Hurley CK. DRB1*14 diversity and DRB3 associations in four major population groups in the United States. Tissue Antigens 2002; 59: 3649.
  • 29
    Kuffner T, Whitworth W, Jairam M, McNicholl J. HLA class II and TNF genes in African Americans from the Southeastern United States: regional differences in allele frequencies. Hum Immunol 2003; 64: 63947.
  • 30
    Sintasath DM, Tang T, Slack R, Tilley EE, Ng J, Hartzman RJ, et al. Relative HLA-DRB1*13 allele frequencies and DRB3 associations of unrelated individuals from five US populations. Hum Immunol 1999; 60: 100110.
  • 31
    Reveille JD, Moulds JM, Ahn C, Friedman AW, Baethge B, Roseman J, et al, for the LUMINA Study Group. Systemic lupus erythematosus in three ethnic groups. I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. Arthritis Rheum 1998; 41: 116172.
  • 32
    Ou D, Mitchell LA, Tingle AJ. A new categorization of HLA DR alleles on a functional basis. Hum Immunol 1998; 59: 66576.
  • 33
    Chinoy H, Salway F, Fertig N, Shephard N, Tait BD, Thomson W, et al. In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype. Arthritis Res Ther 2005; 8: R13.
  • 34
    Just JJ, King MC, Thomson G, Klitz W. African-American HLA class II allele and haplotype diversity. Tissue Antigens 1997; 49: 54755.
  • 35
    Tang TF, Wang J, Slack R, Lin YS, Li L, Heine U, et al. DRB1*03 diversity and DRB3 associations in five major population groups in the United States. Hum Immunol 2002; 63: 2218.
  • 36
    Reche PA, Reinherz EL. Sequence variability analysis of human class I and class II MHC molecules: functional and structural correlates of amino acid polymorphisms. J Mol Biol 2003; 331: 62341.
  • 37
    Fraser PA, Yunis EJ, Alper CA. Excess admixture proportion of extended major histocompatability complex haplotypes of Caucasian origin among rheumatoid arthritis associated haplotypes in African Americans and Afro-Caribbeans. Ethn Health 1996; 1: 1539.
  • 38
    Harley JB, Kelly JA. Genetic basis of systemic lupus erythematosus: a review of the unique genetic contributions in African Americans. J Natl Med Assoc 2002; 94: 6707.
  • 39
    McCarthy BJ, Lipton R, Nichol L. HLA-DQA1 and -DQB1 alleles in Latino and African American children with diabetes mellitus. J Pediatr Endocrinol Metab 2004; 17: 297306.
  • 40
    Price P, Witt C, Allcock R, Sayer D, Garlepp M, Kok CC, et al. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev 1999; 167: 25774.
  • 41
    Charron D. Immunogenetics today: HLA, MHC and much more. Curr Opin Immunol 2005; 17: 4937.
  • 42
    Mori M, Beatty PG, Graves M, Boucher KM, Milford EL. HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry. Transplantation 1997; 64: 101727.
  • 43
    Alarcon GS, Beasley TM, Roseman JM, McGwin G Jr, Fessler BJ, Bastian HM, et al, for the LUMINA Study Group. Ethnic disparities in health and disease: the need to account for ancestral admixture when estimating the genetic contribution to both (LUMINA XXVI). Lupus 2005; 14: 8678.
  • 44
    Ettinger RA, Papadopoulos GK, Moustakas AK, Nepom GT, Kwok WW. Allelic variation in key peptide-binding pockets discriminates between closely related diabetes-protective and diabetes-susceptible HLA-DQB1*06 alleles. J Immunol 2006; 176: 198898.
  • 45
    Falkner D, Wilson J, Fertig N, Clawson K, Medsger TA Jr, Morel PA. Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin). J Rheumatol 2000; 27: 1196202.
  • 46
    Quintero-Del-Rio AI, Kelly JA, Kilpatrick J, James JA, Harley JB. The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3). Genes Immun 2002; 3 Suppl 1: S57.
  • 47
    Nath SK, Kilpatrick J, Harley JB. Genetics of human systemic lupus erythematosus: the emerging picture. Curr Opin Immunol 2004; 16: 794800.
  • 48
    Rider LG, Shamim E, Okada S, Pandey JP, Targoff IN, O' Hanlon TP, et al. Genetic risk and protective factors for idiopathic inflammatory myopathy in Koreans and American whites: a tale of two loci. Arthritis Rheum 1999; 42: 128590.
  • 49
    Shamim EA, Rider LG, Miller FW. Update on the genetics of the idiopathic inflammatory myopathies. Curr Opin Rheumatol 2000; 12: 48291.
  • 50
    Shamim EA, Rider LG, Pandey JP, O'Hanlon TP, Jara LJ, Samayoa EA, et al. Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians: ethnogeographic influences in the genetics and clinical expression of myositis. Arthritis Rheum 2002; 46: 188593.
  • 51
    Okada S, Weatherhead E, Targoff IN, Wesley R, Miller FW, for the International Myositis Collaborative Study Group. Global surface ultraviolet radiation intensity may modulate the clinical and immunologic expression of autoimmune muscle disease. Arthritis Rheum 2003; 48: 228593.